INTEGRATED FILING — Other than Banks



General information about company

Scrip code 000000
NSE Symbol QMSMEDI
MSEI Symbol NOTLISTED
ISIN INE0FMW01018
Name of Company QMS MEDICAL ALLIED SERVICES LIMITED
Type of company SME
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 14-02-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 09-02-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Third quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Healthcare Equipments
Start date and time of board meeting 14-02-2026   13:00:00
End date and time of board meeting 14-02-2026   15:15:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
There are no Debt Securities in the Company and no Defaults on Loans and Debt Securities by the Company.


Financial Results — Other than Bank

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-10-2025 01-04-2025
B Date of end of reporting period 31-12-2025 31-12-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Revenue From Operations
Revenue from operations 2,953.51 11,310.53
Other income 12.92 28.37
Total Income 2,966.43 11,338.90
2 Expenses
(a) Cost of materials consumed 0.00 0.00
(b) Purchases of stock-in-trade 2,106.97 7,483.60
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (549.96) (884.25)
(d) Employee benefit expense 275.48 802.47
(e) Finance costs 206.01 555.17
(f) Depreciation and amortisation expense 91.53 250.15
(g) Other Expenses
1 other expenses 744.41 2,292.29
Total other expenses 744.41 2,292.29
Total expenses 2,874.44 10,499.43
3 Profit before exceptional and extraordinary items and tax 91.99 839.47
4 Exceptional items 0.00 0.00
5 Profit before extraordinary items and tax 91.99 839.47
6 Extraordinary items 0.00 0.00
7 Profit before tax 91.99 839.47
8 Tax Expense
Current tax 29.26 213.75
Deferred tax 5.03 34.10
Total tax expenses 34.29 247.85
9 Net Profit Loss for the period from continuing operations 57.70 591.62
10 Profit (loss) from discontinuing operations before tax 0.00 0.00
11 Tax expense of discontinuing operations 0.00 0.00
12 Net profit (loss) from discontinuing operation after tax 0.00 0.00
13 Profit (loss) for period before minority interest 57.70 591.62
14 Share of profit (loss) of associates
15 Profit (loss) of minority interest
16 Net profit (Loss) for the period 57.70 591.62
17 Details of equity share capital
Paid-up equity share capital 1,933.74 1,933.74
Face value of equity share capital 10 10
18 Reserves excluding revaluation reserve
19 Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.3 1.29
Diluted earnings (loss) per share from continuing and discontinued operations 0.3 1.29
20 Debt equity ratio 0.2900 0.2900
21 Debt service coverage ratio 0.7400 1.1400
22 Interest service coverage ratio 1.9800 3.0700
23 Disclosure of notes on financial results


Remarks

20 Debt equity ratio
21 Debt service coverage ratio
22 Interest service coverage ratio


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-10-2025 01-04-2025
Date of end of reporting period 31-12-2025 31-12-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets
Net Segment Asset
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities
Net Segment Liabilities
Disclosure of notes on segments




Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Amount in (Lakhs)

Mode of Fund Raising Rights Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 23-09-2025
Amount Raised 1,204.83
Report filed for Quarter ended 31-12-2025
Monitoring Agency Applicable
Monitoring Agency Name, if applicable CARE Ratings Limited
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation Not Applicable
Comments of the Audit Committee after review NIL
Comments of the auditors, if any NIL
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Acquisition of Further 25% in Subsidiary, resulting in 76 Holding Not Applicable 1,000.00 0.00 1,000.00 0.00
2 Offer Related Expenses Not Applicable 170.00 0.00 170.00 0.00
3 Funding expenditure for General Corporate Purposes Not Applicable 34.88 34.83 34.24 0.00 The total issue size was Rs.1,204.88 lakhs, while the actual funds received amounted to Rs.1,204.83 lakhs. As this was an SME Rights Issue, wherein allotment must be made in the prescribed lot size of 83 equity shares, the final allotment resulted in a shortfall of 57 equity shares, leading to the minor difference between the issue size and the funds received. Accordingly, the same has been adjusted in Funding expenditure for General Corporate Purposes.


Signatory Details

Name of signatory Mahesh Makhija
Designation of person Managing Director
Place Mumbai
Date 14-11-2025